Overview

A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This study will attempt to find out if the addition of an intravenous form of a drug that is already used for treating asthma in children will help resolve asthma attacks faster than using the current standard care alone.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast